<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="1588">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on October 07, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04424017</url>
  </required_header>
  <id_info>
    <org_study_id>COVID-19\004</org_study_id>
    <nct_id>NCT04424017</nct_id>
  </id_info>
  <brief_title>Sero-prevalence of Coronavirus Disease 2019 (COVID-19) in Healthcare Workers</brief_title>
  <official_title>Sero-prevalence of Coronavirus Disease 2019 (COVID-19) in Healthcare Workers</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Egyptian Center for Research and Regenerative Medicine</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Cairo University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>National Research Center, Egypt</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Academy of Scientific Research and Technology, Egypt</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Egyptian Center for Research and Regenerative Medicine</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The medical and paramedical staff of the front-line services are potentially exposed to
      SARS-CoV-2. Therefore, despite the application of standard protective measures, it is
      possible that a certain number of these personnel have already contracted SARS-CoV-2,
      including in its asymptomatic form. Serological testing in this context would be useful for
      deploying immune healthcare workers as to limit the risk of viral infection and transmission.
      Therefore, it is of utmost importance to prove that the serological response entails the
      production of neutralizing antibodies.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">June 7, 2020</start_date>
  <completion_date type="Anticipated">September 30, 2020</completion_date>
  <primary_completion_date type="Anticipated">September 30, 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Other</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Describe the serological status of individuals in the study by presence of specific anti-SARS-CoV-2 antibodies</measure>
    <time_frame>3 Months</time_frame>
  </primary_outcome>
  <number_of_groups>3</number_of_groups>
  <enrollment type="Anticipated">726</enrollment>
  <condition>COVID</condition>
  <condition>Corona Virus Infection</condition>
  <arm_group>
    <arm_group_label>Healthcare workers (HCWs)</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>Healthy blood donors and healthy subjects in blood bank</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>Convalescents</arm_group_label>
  </arm_group>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>Specific anti-SARS-CoV-2 antibodies</intervention_name>
    <description>A serum sample needs to be collected from each participant upon recruitment into the investigation All samples will be tested by the rapid test (Artron, Artron Laboratories, Burnaby, Canada), IgM / IgG which is an antibody capture Immunochromatografac assay for simultaneous detection of IgM and IgG in serum or plasma for COVID -19 in samples.
All samples will be tested for total Immunoglobulins and IgG in samples for COVID-19 virus by Ortho clinical diagnostics chemiluminescent technique (Ortho, Raritan, USA).</description>
    <arm_group_label>Convalescents</arm_group_label>
    <arm_group_label>Healthcare workers (HCWs)</arm_group_label>
    <arm_group_label>Healthy blood donors and healthy subjects in blood bank</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Age-stratified sample from general population with 3 subgroups:

          1. Healthcare workers (HCWs), comprising frontline doctors, nurses, health attendants,
             and receptionists.

          2. Healthy blood donors and healthy subjects in blood bank or laboratory (routine
             examinations as pre-employment, likely to be representative of the general population

          3. Convalescents
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Not previously diagnosed with COVID-19 except for convalescents

          -  Not currently symptomatic with fever or respiratory symptoms (cough, dyspnea)

        Exclusion Criteria:

          -  Patients with fever or respiratory symptoms (cough, dyspnea)

          -  Refusal to give informed consent, or contraindication to venipuncture.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>ECRRM</name>
      <address>
        <city>Cairo</city>
        <zip>32</zip>
        <country>Egypt</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Khaled E Amer, MD</last_name>
      <phone>+201009380400</phone>
      <email>dramertx@gmail.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Faculty of Medicine, Cairo University</name>
      <address>
        <city>Cairo</city>
        <country>Egypt</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Abdel Meguid Kassem, MD</last_name>
      <phone>00201001768255</phone>
      <email>kassem@git.eg.net</email>
    </contact>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <verification_date>August 2020</verification_date>
  <study_first_submitted>June 8, 2020</study_first_submitted>
  <study_first_submitted_qc>June 8, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">June 9, 2020</study_first_posted>
  <last_update_submitted>August 8, 2020</last_update_submitted>
  <last_update_submitted_qc>August 8, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">August 11, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Coronavirus Infections</mesh_term>
    <mesh_term>Severe Acute Respiratory Syndrome</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Antibodies</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

